Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01961115
Title INCB024360 and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center
Indications

melanoma

Therapies

Epacadostat

MELITAC 12.1 Peptide Vaccine

Age Groups: adult
Covered Countries USA


No variant requirements are available.